Driver mutations implicated in MPNs

Автор: VJHemOnc – Video Journal of Hematology & HemOnc

Загружено: 26 авг. 2021 г.

Просмотров: 194 просмотра

Описание:

Stephen Oh, MD, PhD, Washington University School of Medicine, St. Louis, MO, discusses driver mutations for myeloproliferative neoplasms (MPNs) such as JAK2, CALR, and MPL, all of which result in some degree of activation of the JAK/STAT signalling pathway. Dr Oh also talks on the impacts of secondary mutations such as splicing mutations that play a role in the pathogenesis of MPNs, highlighting their prognostic implications. This interview took place at the Texas MPN Workshop: Second Annual Workshop and Meeting in 2021.

Driver mutations implicated in MPNs

Доступные форматы для скачивания:

Скачать видео mp4

Информация по загрузке:

Скачать аудио mp3

Похожие видео

Diet as an approach to reduce inflammation in patients with MPNs

Diet as an approach to reduce inflammation in patients with MPNs

Thrombopoietin receptor MPL: a potential therapeutic target for MPNs

Thrombopoietin receptor MPL: a potential therapeutic target for MPNs

Translational insights into T-cell engagers and CAR T-cell therapy: targets, the microbiome, & more

Translational insights into T-cell engagers and CAR T-cell therapy: targets, the microbiome, & more

The Antibiotic Ladder Revisited: Anti-infective Therapy Part 2

The Antibiotic Ladder Revisited: Anti-infective Therapy Part 2

LLM и GPT - как работают большие языковые модели? Визуальное введение в трансформеры

LLM и GPT - как работают большие языковые модели? Визуальное введение в трансформеры

Myeloproliferative Neoplasm [Hot Topic]

Myeloproliferative Neoplasm [Hot Topic]

What Cardiovascular Tests Can Save Your Life

What Cardiovascular Tests Can Save Your Life

Use of Molecular Genetic Testing in MDS and MPN

Use of Molecular Genetic Testing in MDS and MPN

Prognostic Artificial Intelligence Scores and Outcomes in Nonmetastatic Prostate Cancer

Prognostic Artificial Intelligence Scores and Outcomes in Nonmetastatic Prostate Cancer

Real-World Database Study Affirms Long-Term Benefit of Hydroxyurea for Anemia in Pediatric SCD

Real-World Database Study Affirms Long-Term Benefit of Hydroxyurea for Anemia in Pediatric SCD